CHICAGO, May 14, 2024 /PRNewswire/ -- Data infrastructure and analytics company Kalderos, creator of the world's first Drug Discount Management platform, today announced the hiring of life sciences legal professional Daryl Todd as chief strategy officer.To download a headshot of Todd, click here.An experienced senior regulatory attorney, Todd is skilled in compliance, commercial contracting, and regulatory law with extensive experience in the pharmaceutical industry. He comes to Kalderos from Johnson & Johnson, where he served as assistant general counsel, focused on legal, compliance, and consumer cost issues. There, he helped create patient-based programs, including copay, voucher, and innovative free-product programs. He also structured collaborative arrangements with hospitals and other healthcare stakeholders.Todd spent more than a decade serving as a board member of the Johnson & Johnson Foundation and Johnson & Johnson Patient Assistance Foundation. At those organizations, he served as lead attorney and helped develop programs that assisted low-income patients with access to their prescribed medicines.As chief strategy officer at Kalderos, Todd will work with Chief Executive Officer Angie Franks and other team members to position the company for further growth and solidify its status as the market leader for drug discount management solutions. A significant focus will be creating new and innovative ways to address drug discount challenges with an eye toward driving more discount value to consumers."Daryl's experience with hospitals and drug manufacturers, besides his meaningful work with patients and doctors, gives us valuable insights into 340B, Medicaid, and commercial drug discount programs designed to lower the price of drugs for consumers," said Franks

Daryl Todd, Chief Strategy Officer at KalderosWhat You Should Know: – Kalderos, the data infrastructure and analytics company behind the world’s first Drug Discount Management platform, has appointed Daryl Todd as its new Chief Strategy Officer. – Todd, a seasoned legal professional with extensive experience in the life sciences industry, brings a unique combination of legal expertise and patient advocacy to the table.Building on a Strong LegacyTodd’s impressive career boasts senior regulatory attorney roles, with a deep understanding of compliance, commercial contracting, and regulatory law. Before joining Kalderos, he served as Assistant General Counsel at Johnson Johnson, focusing on legal, compliance, and consumer cost issues. In this role, he played a pivotal role in:Creating patient-centric programs to improve medication access, including copay assistance, vouchers, and innovative free-product initiatives.Structuring collaborative arrangements with hospitals and other healthcare stakeholders.A Passion for Patient AdvocacyTodd’s commitment extends beyond legal expertise. For over a decade, he served as a board member for both the Johnson Johnson Foundation and the Johnson Johnson Patient Assistance Foundation. As lead attorney for these organizations, he played a key role in developing programs that helped low-income patients afford their prescribed medications.Prior to Johnson Johnson, Todd held senior counsel positions at both Bristol-Myers Squibb, where he worked on hospital agreements and patient assistance programs, and McCarter English, where he represented hospitals in legal matters. He holds a law degree from Rutgers Law School and a bachelor’s degree in American History from the University of Pennsylvania.Shaping the Future of Drug Discount ManagementAt Kalderos, Todd will collaborate with CEO Angie Franks and the leadership team to propel the company’s growth and solidify its position as the leading provider of drug discount management solutions

When it comes to choosing a career in accounting, the numbers no longer add up. That’s because, from corporate finance departments to CPA (certified public accountant) prep courses, finance functions across America are suffering from an ongoing attrition of their most seasoned team members while the accounting profession as a whole is failing to replace them by drawing in the next generation of workers. In 2023 alone, over 720 companies cited insufficient staffing levels across key financial and accounting departments and noted that the lack of help meant there could be potential errors in their reporting, per a March report from Bloomberg